Shows
The Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 114: A Discussion of Lifestyle and risk factor modification in atrial fibrillation...Melissa E. Middeldorp, MPH, PhD is joined by Thomas F. Deering, BS, MBA, MD, FHRS, CCDS, and T. Jared Bunch, MD, FHRS to discuss a 31-item questionnaire was developed and distributed among healthcare professionals via the EHRA network and social media between 23 September and 21 October 2024. https://www.hrsonline.org/education/TheLead https://academic.oup.com/europace/article/27/4/euaf075/8099191?login=false Host Disclosure(s): M. Middeldorp: Nothing to disclose. Contributor Disclosure(s): T. Deering: Honoraria/Speaking/Consulting: Sanofi, Pacemate, P...2025-07-3115 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 113: A Discussion on the Effect of Pulsed Field Ablation on Human Coronary Arteries...Please join host Michael S. Lloyd, MD, FHRS at HRS 2025 in San Diego as he discusses this article with Stephanie Wang, MD and Emily Zeitler, MD. The study investigated whether PFA-induced coronary spasms during ablation could cause lasting changes—such as mild lumen narrowing—at the ablation site over a three-month period. https://www.hrsonline.org/education/TheLead https://www.jacc.org/doi/10.1016/j.jacep.2025.03.014 Host Disclosure(s): M. Lloyd: Honoraria/Speaking/Consulting: Medtronic, Arga Medtech, Circa Scientific Membership on Advisory Committees: Boston Scientific 2025-07-2414 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 107: A Discussion of Catheter Ablation of AFib in Cardiac Sarcoidosis and Amyloidosis...Join HRS Board Member Prashanthan Sanders, MBBS, PhD, FHRS (University of Adelaide) as he discusses this exciting paper, presented at Heart Rhythm 2025. He is joined in the Heart Rhythm Tv Studio in San Diego, California by Louise Segan, MBBS, MPH (Alfred Health), and Takanori Yamaguchi, MD, PhD (Saga University). This discussion took place on-site at Heart Rhythm 2025. https://www.hrsonline.org/education/TheLead https://www.heartrhythmjournal.com/article/S1547-5271(25)01245-7/fulltext Host Disclosure(s): P. Sanders: Honoraria/Speaking/Consulting: Boston Scientific, Abbott Medical, Research: Boston Scientific, A...2025-06-1212 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 106: A Discussion of 1st-in-Human Study of a Leadless Pacemaker System...Prashanthan Sanders, MBBS, PhD, FHRS, University of Adelaide is joined by Jenish Shroff, MBBS, MD, Australian National University, and Pugazhendhi Vijayaraman, MD, FHRS, Geisinger Heart Institute, to discuss this first-in-human feasibility study evaluated a novel helix-based leadless pacemaker (LPCSP) designed to achieve left bundle branch area pacing (LBBAP), a capability current LPs lack. The device was temporarily implanted via the internal jugular vein into the interventricular septum in 14 patients, with successful implantation in 10. Electrical performance metrics, including pacing threshold, R-wave amplitude, and impedance, were within acceptable clinical ranges. LBBAP capture was achieved in 5 patients, with no serious device-related adverse...2025-06-0518 min
Health News Tracker"Health Care's Tech-Driven Transformation Amid Budgetary Shifts and Regulatory Uncertainty"Over the past 48 hours, the health care industry has seen heightened volatility and pivotal developments. The release of the U.S. Department of Health and Human Services 2026 budget proposal has dominated recent headlines, calling for a drastic 25 percent cut in discretionary funding, from 127 billion dollars in 2025 to 95 billion in 2026. This has triggered broad uncertainty, with concerns mounting over the future of programs like Medicaid, which faces demands for even deeper and faster cuts from some lawmakers. Compared to previous years, these proposed reductions mark one of the most significant retrenchments in federal health spending in decades and could potentially impact...2025-06-0302 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 105: A Discussion of...Acute Results of the Volt-AF IDE Trial...Michael S. Lloyd, MD, FHRS, Emory University is joined by Edward P. Gerstenfeld, MD, MS, FHRS, University of California, San Francisco, and Christopher C Cheung, MD, MPH, FHRS, Sunnybrook HSC, University of Toronto, to discuss the VOLT-AF IDE study evaluated the safety and effectiveness of a novel balloon-based pulsed field ablation (PFA) catheter system for treating paroxysmal and persistent atrial fibrillation (PAF and PsAF). Conducted at 34 global sites, the study enrolled 394 subjects, with 320 included in the primary analysis. Acute pulmonary vein isolation (PVI) success was achieved in over 99% of veins, and primary serious adverse events occurred in only 1.9% of...2025-05-2917 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 104: A Discussion of Implantable Loop Recorder &Arrhythmia Detection in HCM...Live at HRS 2025Sandeep A Saha, MD, MS, FHRS, Oregon Heart Center PC is joined by Saket Sanghai, MD, FHRS, Oregon Health & Science University, and Naga Venkata Krishna Chand Pothineni, MD, Kansas City Heart Rhythm Institute, to discuss how the study evaluated the effectiveness of implantable loop recorders (ILRs) in detecting arrhythmias in patients with hypertrophic cardiomyopathy (HCM). Traditional monitoring methods, like Holter monitors, often miss intermittent arrhythmic events in HCM patients. ILRs, offering continuous long-term monitoring, were found to identify clinically significant arrhythmias that might otherwise go undetected. The findings suggest that ILRs can play a crucial role in risk stratification...2025-05-2221 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 102: A Discussion of Repeat Procedures After Pulsed Field Ablation for Atrial FibrillationJoin host Michael S. Lloyd, MD, FHRS and episode guests Ante Anic, MD and Konstantinos Vlachos, MD as they discuss the recent article Repeat Procedures after Pulsed Field Ablation for Atrial Fibrillation, the MANIFEST-REDO Study, from Europace. This episode was recorded in-person at EHRA 2025. Bonus video footage of the episode is available on heartrhythm265.org. https://www.hrsonline.org/education/TheLead https://academic.oup.com/europace/advance-article/doi/10.1093/europace/euaf012/7958418 Host Disclosure(s): M. Lloyd: Honoraria/Speaking/Consulting: Medtronic, Arga Medtech, Circa Scientific Membership on Ad...2025-05-0812 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 101: A Discussion of Pulsed Field or Cryoballoon Ablation...Join host Prashanthan Sanders, MBBS, PhD, FHRS, and episode guests Jason G. Andrade, MD, FHRS, and Melanie Gunawardene, MD, as they discuss Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation. This discussion was recorded in person at EHRA 2025 in Vienna, Austria. The article under discussion was presented at EHRA 2025 and simultaneously published in the New England Journal of Medicine. https://www.hrsonline.org/education/TheLead https://www.nejm.org/doi/full/10.1056/NEJMoa2502280 Host Disclosure(s): P. Sanders: Honoraria/Speaking/Consulting: Boston Scientific, Abbott Medical2025-05-0109 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 99: A Discussion of Artificial Intelligence for Individualized Treatment...Join host and Digital Education Chair Prashanthan Sanders, MBBS, PhD, FHRS, as he discusses this article from Nature with guests Anand N Ganesan, MBBS, PhD, and Tina Baykaner, MD, MPH. This trial was also presented as a late-breaking clinical trial at Heart Rhythm 2024. https://www.hrsonline.org/education/TheLead https://www.nature.com/articles/s41591-025-03517-w Host Disclosure(s): P. Sanders: Honoraria/Speaking/Consulting: Boston Scientific, Abbott Medical Research: Boston Scientific, Abbott, Medtronic, Becton Dickinson, CathRx, Pacemate, Kalyan Technologies, Ceryx Medical, Biosense Webster, In...2025-04-1016 min
ESC TV Today – Your Cardiovascular NewsCurrent indications for pulmonary vein isolation - Conduction system pacingThis episode covers: Cardiology This Week: A concise summary of recent studies Current indications for pulmonary vein isolation Conduction system pacing EHRA 2025 scientific highlights Host: Susanna Price Guests: Haran Burri, Isabel Deisenhofer, Helmut Puererfellner, Emma Svennberg Want to watch that episode? Go to: https://esc365.escardio.org/event/1803 Disclaimer ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health c...2025-04-1022 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 98: A Discussion of Effect of targeted education of patients with atrial fibrillation...Host Melissa E. Middeldorp, MPH, PhD, of the University Medical Centre Groningen & University of Adelaide, is joined by Andrea Robinson, MSN, ACNP, from Riverside Methodist Hospital, OhioHealth, and Jeroen ML Hendriks, PhD, RN, of Maastricht University Medical Centre, in this episode. The AF-EduCare trial investigated whether targeted patient education (delivered in-person or online) could reduce unplanned cardiovascular events in patients with atrial fibrillation (AF). The study found that while education improved patient knowledge, medication adherence, and risk factor awareness, it did not significantly reduce cardiovascular hospitalizations, emergency visits, or mortality compared to standard care. However, subgroup analyses...2025-04-0321 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 97: A Discussion of Pulmonary Vein Isolation versus SHAM Intervention...Michael S. Lloyd, MD, FHRS, Emory University, is joined by Harish Doppalapudi, MD, FHRS, University of Alabama at Birmingham, to discuss this provocative article from late 2024 on Pulmonary Vein Isolation versus SHAM Intervention in Symptomatic Atrial Fibrillation. Special thanks to Prashant D. Bhave, MD, FHRS for his contributions to the discussion. https://www.hrsonline.org/education/TheLead https://jamanetwork.com/journals/jama/fullarticle/2823283#google_vignette Host Disclosure(s): M. Lloyd: Honoraria/Speaking/Consulting: Medtronic, Membership on Advisory Committees: Boston Scientific Contributor Disclosure(s): H. Doppalapudi: Honoraria/Speaking...2025-03-2714 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 95: A Discussion of Personalized Voltage Maps Guided by Cardiac Magnetic Resonance...William H. Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital, is joined by Arif Elvan, MD, PhD, Klinikum Braunschweig, and Usha B. Tedrow, MD, MS, FHRS, Brigham and Women’s Hospital, to discuss if Voltage mapping could identify the conducting channels potentially responsible for ventricular tachycardia (VT). Standard thresholds (0.5–1.5 mV) were established using bipolar catheters. No thresholds have been analyzed with high-density mapping catheters. In addition, channels identified by cardiac magnetic resonance (CMR) have been proven to be related to VT. https://www.hrsonline.org/education/TheLead https://doi.org/10.1016/j.hrthm.2024.04.074 Host Disc...2025-03-1316 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 94: A Discussion of Atrial Fibrillation Nomenclature, Definitions, and Mechanisms...Deep Chandh Raja, MBBS, MD, PhD, Australian National University, Kauvery Hospital, is joined by Dhiraj Gupta, MBBS, MD, Liverpool Heart and Chest Hospital, and Dominik K Linz, MD, PhD, Maastricht University Medical Center, to discuss a international position paper, developed by the Working Group of the Signal Summit, highlights the challenges in understanding and treating atrial fibrillation (AF), the most common arrhythmia in adults. Despite technological advancements in pulmonary vein isolation (PVI), progress in understanding AF mechanisms, structural changes, and phenotypic differences has been limited due to inconsistent terminology, suboptimal mapping techniques, and the complex nature of AF itself...2025-03-0628 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 93: A Discussion of Safety of pulsed field ablation in more than 17,000 patients with AFib...William Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by Tobias Reichlin, MD, University Hospital Basel, Switzerland, and Nikolas Nozica, MD, Brigham and Women's Hospital, to discuss the Nature Medicine article Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study. The following is a brief summary of the study covered in the article. Pulsed field ablation (PFA) is an emerging technology for the treatment of atrial fibrillation (AF), for which pre-clinical and early-stage clinical data are suggestive of some degree of preferentiality to myocardial tissue ablation without...2025-02-2717 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 92: A Discussion of Substrate Mapping for Ventricular Tachycardia Ablation...William Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by Wendy Tzou, MD, FHRS, University of Colorado Anschutz Medical Campus, and Arif Elvan, MD, PhD, Klinikum Braunschweig, to discuss a partial delineation of targets for ablation of ventricular tachycardia (VT) during a stable rhythm is likely responsible for a suboptimal success rate. The abnormal low-voltage near-field functional components may be hidden within the high-amplitude far-field signal. https://www.hrsonline.org/education/TheLead https://doi.org/10.1016/j.jacep.2024.04.023 Host Disclosure(s): W. Sauer: Honoraria/Speaking/Consulting: Biotronik, Biosense Webster, Inc., Abbott...2025-02-2018 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 90: A Discussion of Catheter Ablation or Antiarrhythmic Drugs for VTWilliam H. Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by Isabella Alviz, MD, Brigham, and Women’s Hospital, and Usha B. Tedrow, MD, MS, FHRS, Brigham and Women’s Hospital to discuss how patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular tachycardia. Whether catheter ablation is more effective than antiarrhythmic drugs as a first-line therapy in patients with ventricular tachycardia is uncertain. https://www.hrsonline.org/education/TheLead https://www.nejm.org/doi/full/10.1056/NEJMoa2409501 2025-02-0618 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 89: A Discussion of Vasovagal Responses to Human Monomorphic Ventricular Tachycardia...Dr. Jason T. Jacobson, MD, FHRS, Westchester Medical Center, New York Medical College is joined by Melissa Robinson, MD, FHRS, Providence Heart Institute of Montana, and Dr. Sei Iwai, MD, FHRS, Westchester Medical Center, New York Medical College to discuss: BACKGROUND Factors determining hemodynamic stability during human ventricular tachycardia (VT) are incompletely understood. OBJECTIVES This study aimed to characterize sinus rate (SR) responses during monomorphic VT in association with hemodynamic stability and prospectively assess the effects of vagolytic therapy on VT tolerance. METHODS This is a retrospective analysis of patients undergoing scar-related VT ablation...2025-01-3015 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 88: A Discussion of Ablation for Atrial Fibrillation in Patients With Rare Pathogenic Variants...William H. Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by Ezim Ajufo, MD, Brigham and Women’s Hospital and Victor Nauffal, MD, Brigham and Women’s Hospital to discuss the Patients with rare, pathogenic cardiomyopathy (CM) and arrhythmia variants that can present with atrial fibrillation (AF). The efficacy of AF ablation in these patients is unknown. This study tested the hypotheses that: 1) patients with a pathogenic variant in any CM or arrhythmia gene have increased recurrence following AF ablation; and 2) patients with a pathogenic variant associated with a specific gene group (arrhythmogenic left ventricular CM [ALVC], arrh...2025-01-2320 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 86: A Discussion of A Discussion of Radiofrequency catheter ablation of persistent atrial fibrillation by pulmonary vein isolation...William H. Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by Jorge Romero, MD, FHRS, Brigham and Women's Hospital-Harvard Medical School, and Joshua Cooper, MD, FHRS, Temple University Health System to discuss how the posterior wall isolation (PWI) is commonly incorporated into catheter ablation (CA) strategies for persistent atrial fibrillation (AF) in an attempt to improve outcomes. In the CAPLA randomized study, adjunctive PWI did not improve freedom from atrial arrhythmia at 12 months compared with pulmonary vein isolation (PVI) alone. Whether additional PWI reduces arrhythmia recurrence over the longer term remains unknown. https://www.hrsonline.o...2025-01-0916 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 85: A Discussion of Bipolar RF Ablation of Refractory Ventricular Arrythmias...Join Michael Lloyd and his guests Wendy Tzou, and Jason Jacobson as they discuss this late breaker in person at APHRS 2024 in Sydney, Australia. https://www.hrsonline.org/education/TheLead https://pubmed.ncbi.nlm.nih.gov/39331050/ Host Disclosure(s): M. Lloyd: Honoraria/Speaking/Consulting: Medtronic, Membership on Advisory Committees: Boston Scientific Contributor Disclosure(s): J. Jacobson: Honoraria/Speaking/Teaching/Consulting: Zoll Medical, Vektor Medical, Inc., Abbott Medical, Research (Contracted Grants): CardioFocus, Inc., Stocks, Privately Held: Atlas 5D W. Tzou: Research (Contracted Grants): Abbott Medical, Membership on A...2024-12-1921 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 84: A Discussion of Arrhythmic prognosis to LV systolic dysfunction severity...William H. Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by Edoardo Bressi, MD Queen Elizabeth Hospital - University Hospitals Birmingham, and Jordana Kron, MD Virginia Commonwealth University to discuss the current guidelines that present varying classes of recommendations for implantable cardioverter-defibrillator (ICD) utilization in patients with cardiac sarcoidosis (CS) and left ventricular ejection fraction (LVEF) 2024-12-1217 min
Critical Mass Business Talk Show | Orange County’s Longest-Running Business Talk ShowCritical Mass Business Talk Show: Ric Franzi Interviews Jasmina (Jass) Brooks, President, Electrophysiology - Johnson & Johnson MedTech (Episode 1558)Jasmina (Jass) Brooks is President, Electrophysiology, Johnson & Johnson MedTech (formerly Biosense Webster, Inc.), a global leader in the science, diagnosis and treatment of heart rhythm disorders.
Jass is a seasoned leader with more than 25 years of experience in the cardiovascular field, primarily focused on electrophysiology. She has accountability for setting the J&J MedTech Electrophysiology end-to-end global strategy as a leader in cardiac ablation, advancing its innovation agenda, and driving execution to position the organization for continued growth.
Previously, Jass was Vice President, Global Strategic Marketing, Biosense Webster, Inc. In this role, she worked with...2024-12-1025 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 82This review of the results from the International Collaborative LBBAP Study (I-CLAS Group) was discussed live and in person at the Asia Pacific Heart Rhythm Society 2024 meeting in Sydney, Australia. It is presented in collaboration with Heart Rhythm TV. https://www.hrsonline.org/education/TheLead https://www.heartrhythmjournal.com/article/S1547-5271(24)03330-7/abstract Host Disclosure(s): J. Jacobson: Honoraria/Speaking/Consulting: Zoll Medical, Abbott Medical, Vektor Medical, Stocks, Privately Held: Atlas 5D, Research: CardioFocus, Inc. Contributor Disclosure(s): T. Bunch: Honoraria/Speaking/Consulting: Heart Rhythm S...2024-11-2114 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 81William H. Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by Sanjay Divakaran, MD, MPH, Brigham and Women's Hospital and Xiaoxiao Qian, MD, Brigham, and Women's Hospital to discuss the 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/magnetic resonance (MR) can identify inflammation and fibrosis, which are high-risk features in cardiac sarcoidosis. https://www.hrsonline.org/education/TheLead https://doi.org/10.1016/j.hrthm.2024.09.011 Host Disclosure(s): W.Sauer: Honoraria/Speaking/Consulting: Biotronik, Biosense Webster, Inc., Abbott, Boston Scientific, Research: Medtronic Contributor Disclosure(s): S. Divakaran: H...2024-11-1417 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 80This episode is a discussion of the paper entitled, "Catheter Ablation versus Advanced Therapy for Patients with Severe Heart Failure and Ventricular Electrical Storm." https://www.hrsonline.org/education/TheLead https://doi.org/10.1016/j.hrthm.2024.09.045 Host Disclosure(s): W.Sauer: Honoraria/Speaking/Consulting: Biotronik, Biosense Webster, Inc., Abbott, Boston Scientific, Research: Medtronic Contributor Disclosure(s): R. Kerley: Nothing to disclose. A. Desai: Research: Novartis, Bayer Healthcare Pharmaceuticals, Abbott Medical, AstraZeneca, Honoraria/Speaking/Consulting: Novartis, Abbott, AstraZeneca, Regerneron, Alnylam Pharmaceuticals, Bayer Healthcare Pharmaceutricals, Cytokinetics, AxonTherapies, Avidity B...2024-11-0716 min
ESC TV Today – Your Cardiovascular NewsStrategic decisions in afib - Critical evaluation of clinical trialsESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology this Week: A concise summary of recent studies Strategic decisions in atrial fibrillation Critical evaluation of clinical trials Snapshots Host: Perry Elliott Guests: Stephan Achenbach, Carlos Aguiar, Jane Armitage, Isabel Deisenhofer Want to watch that episode? Go to: https://esc365.escardio.org/event/1720 Disclaimer ESC TV Today is supported by Bristol Myers Squibb. This scientific content and opinions...2024-09-2621 min
Consciously CluelessConsciously Cannabis - From Recreation to Remedy: A Deep Dive into Cannabis and Psychedelic Therapies with Stephanie Karzon Abrams, MSc Clin. PharmOur guest's journey with cannabis began as a youthful experiment but transformed into a profound exploration of its medicinal and truth-telling properties. In this episode of Consciously Cannabis, Stephanie Karzon shares her evolution with cannabis, moving from casual use to a deeper appreciation for its potential for mental and physical wellness.
From setting up an integrative medicine clinic in LA to understanding the holistic approach to women's health, Stephanie shares insights into combining Western medical practices with alternative therapies. We explore the significance of treating the whole person rather than just symptoms and the potential of psychedelic therapies in neurological...2024-08-2154 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 74Niraj Sharma, MD, FHRS, Northside Hospital is joined by Rhea Pimentel, BChir, MD, FHRS, University of Kansas Health System and Usman Siddiqui, MD, Florida Cardiology Advent Health Systems, Orlando, to discuss how the FLUTFIB study aimed to assess the incidence, duration, timing, and symptoms of atrial fibrillation (AF) after cavotricuspid isthmus (CTI) ablation in patients with atrial flutter (AFL). The study included 100 patients with AFL, who received implantable loop recorders for continuous AF monitoring following CTI ablation. Over a median follow-up of 24 months, 77% of patients experienced AF episodes, typically occurring around 180 days post-ablation. Most AF episodes lasted over an...2024-08-1518 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 73William H. Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by Rod S. Passman, MD, FHRS, Northwestern University and Graham Peigh, MD, MS, Northwestern Memorial Hospital to discuss the direct oral anticoagulants (DOACs) reduce stroke risk in patients with device-detected atrial fibrillation (DD-AFib) but increase major bleeding risk. The time to benefit (TTB) and time to harm (TTH) are not well quantified. https://www.hrsonline.org/education/TheLead https://www.heartrhythmjournal.com/article/S1547-5271(24)02812-1/fulltext#secsectitle0055 Host Disclosure(s): W. Sauer: Honoraria/Speaking/Consulting: Biotronik, Biosense W...2024-08-0818 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 71William H. Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by Andrés Felipe Miranda-Arboleda, MD, Brigham and Women's Hospital Babak Nazer, MD, University of Washington to discuss how Purkinje fibers play an important role in the initiation and maintenance of ventricular fibrillation (VF) and polymorphic ventricular tachycardia (PMVT). Fascicular substrate modification (FSM) approaches have been suggested to treat recurrent VF in case reports and small case series. https://www.hrsonline.org/education/TheLead https://www.jacc.org/doi/10.1016/j.jacep.2024.03.035 Host Disclosure(s): W. Sauer: Honoraria/Speaking/Consulting: B...2024-07-2523 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 70Michael S. Lloyd, MD, FHRS, Emory University, is joined by Jayanthi N. Koneru, MBBS, FHRS, VCU Medical Center, Cardiology, and S. Patrick Whalen, MD, FHRS, Wake Forest University, School of Medicine to discuss the practical applications of the updated guidelines and their impact on the global field of EP. https://www.hrsonline.org/education/TheLead https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11000153/ Host Disclosure(s): M. Lloyd: Honoraria/Speaking/Consulting: Medtronic, Baylis Medical Company, Boston Scientific. Contributor Disclosure(s): J. Koneru: Honoraria/Speaking/Consulting: M...2024-07-1823 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 68Jason T. Jacobson, MD, FHRS, Westchester Medical Center-New York Medical College is joined by Jose Carlos Pachon-Mateos, MD, PhD, Sao Paulo Heart Hospital, and Sunny S. Po, MD, PhD, FHRS, University of Oklahoma, Health Sciences Center to discuss the porcine model of cardioneuroablation is tested for vagal denervation effects at 6 weeks. The model is further tested for enhanced susceptibility to ventricular arrhythmias during myocardial ischemia of ablated animals. https://www.hrsonline.org/education/TheLead https://doi.org/10.1016/j.hrthm.2023.08.001 Host Disclosure(s): J. Jacobson: Honoraria/Speaking/Consulting: American College of Cardiology...2024-07-0326 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 66William H. Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by Edward P. Gerstenfeld, MD, MS, FHRS, University of California, San Francisco, and Yasser Rodriguez, MBA, MD, Cleveland Clinic Florida to discuss; Background: Premature ventricular complexes (PVCs) are common and associated with worse outcomes in patients with heart failure. Class 1C antiarrhythmic drugs (AADs) effectively suppress PVCs, but guidelines currently restrict their use in structural heart disease. Conclusions: Class 1C AADs effectively suppressed PVCs in patients with NICM and ICDs, leading to increases in LVEF and biventricular pacing percentage. In this limited sample...2024-06-2020 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 62 Live from BostonThe Lead is a journal review podcast designed to keep listeners up to date and informed on the latest publications and hottest topics in electrophysiology. The Lead’s session at Heart Rhythm 2024 includes three discussions, covering Transvenous Extraction of Conduction System Pacing Leads: An International Multicenter (TECSPAM) study and Safety, Efficacy, and Reliability Evaluation of a Novel Small-Diameter Defibrillation Lead: Global LEADR Pivotal Trial Results from the May 2024 issue of Heart Rhythm Journal, as well as Tachycardia therapy and Endpoint Results of the First Modular, Intra-body, Communicating Subcutaneous Defibrillator-Leadless Pacemaker System: MODULAR ATP Interim Cohort from the May 2024 issue of...2024-05-2351 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 60Deepthy Varghese, MSN, ACNP, FNP, Northside Hospital, is joined by Shephal K Doshi, MD Pacific Heart Institute, and Devi G. Nair, MD, FHRS, St. Bernards Medical Center & Arrhythmia Research Group to discuss how the retrospective cohort study examined the safety and efficacy of combining left atrial appendage occlusion (LAAO) with other cardiac procedures compared to isolated LAAO. Based on data from the National Inpatient Sample database, the analysis found similar rates of major adverse cardiovascular events (MACEs) and length of stay (LOS) between the two groups. However, patients undergoing concomitant procedures had higher costs and certain complications were more...2024-05-0216 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 59Jason T. Jacobson, MD, FHRS, Westchester Medical Center-New York Medical College, is joined by William H. Sauer, MD, FHRS, Brigham and Women's Hospital, and Christian Thomas Ruff, MD, Brigham and Women's Hospital to discuss a meta-analysis of the 2 recent randomized controlled trials of oral anticoagulation vs aspirin and placebo for atrial high rate episodes detected by cardiac implanted electronic devices. The trials included are NOAH-AFNET6 and ARTESIA, which reported discordant results. When analyzed together, this study shows that anticoagulation does decrease embolic risk in this patient population. https://www.hrsonline.org/education/TheLead https://w...2024-04-2520 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 56William H. Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by guest Amin Al-Ahmad, MD, FHRS, CCDS, Texas Cardiac Arrhythmia Institute and Jorge Romero, Jr., MD, FHRS, Brigham and Women's Hospital to discuss how Pulsed-field ablation (PFA) is a novel nonthermal ablation technology with high procedural safety and efficiency for pulmonary vein isolation (PVI). Premarket data showed high PVI durability during mandatory remapping studies. Data on lesion durability in real-world patients with clinically indicated redo procedures are scarce. In this episode of The Lead, we discuss why and how this study sought to report PVI durability rates...2024-04-0417 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 53William H. Sauer, MD, FHRS, CCDS, of Brigham and Women's Hospital is joined by guests Akshay Suvas Desai, MD, MPH of Brigham and Women's Hospital, and Sunil Kapur, MD of Brigham and Women`s Hospital to discuss how the Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT) showed a greater benefit with respect to mortality at 5 years among patients who received cardiac-resynchronization therapy (CRT) than among those who received implantable cardioverter–defibrillators (ICDs). However, the effect of CRT on long-term survival is not known. We randomly assigned patients with New York Heart Association (NYHA) class II or III heart fail...2024-03-1418 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 52Deepthy Varghese, MSN, ACNP, FNP, of Northside Hospital, is joined by Dr. Mikhael F. El-Chami, MD, FHRS of Emory University, School of Medicine, and Dr. Rohit Mehta, MD, FHRS, with Advocate Health to discuss the study evaluated the preclinical performance and safety of retrieving chronically implanted dual-chamber leadless pacemakers (LPs). A total of 18 LPs were implanted in 9 ovine subjects, and after approximately 2 years, all LPs were successfully retrieved using a dedicated transvenous retrieval catheter. The retrieval procedure duration ranged from 2.5 to 36.4 minutes. Postretrieval analysis showed minimal tissue disruption at implant sites, and no significant device-related complications or injuries were...2024-03-0718 min
Fast Five Medtech News PodcastMedtronic asks ITC to stop Axonics' neuromod device sales; J&J's Varipulse PFA wins CE mark approvalWelcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 1, 2024.
Check out the show notes at MassDevice.com/podcast.
Orthofix this week appointed a new president of its Bone Growth Therapies business. Fast Five hosts Danielle Kirsh and Sean Whooley discuss who is joining the company and some of their career experience.
Affluent Medical has positive biomimetic mitral valve data. Learn more about the valve and some of the data points that study out.
Onward won an FDA br...2024-03-0110 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 51Dr. Jason T. Jacobson, MD, FHRS of Westchester Medical Center-New York Medical College is joined by guest Jeffrey R. Winterfield, MD, FHRS of The Medical University of South Carolina, and Dr. Isabel Deisenhofer, MD, FHRS of German Heart Center Munich Department of Electrophysiology to discuss how the Omnipolar mapping provides greater specificity for late potentials, with higher sensitivity and specificity for deceleration zones and ventricular tachycardia isthmuses compared with bipolar mapping. https://www.hrsonline.org/education/TheLead https://www.heartrhythmjournal.com/article/S1547-5271(23)02408-6/fulltext Host Disclosure(s): J. Jacobson: Honoraria/Speaking...2024-02-2921 min
Fast Five Medtech News PodcastA high-ranking BD executive is set to retire; J&J’s Biosense Webster begins trial for Laminar LAAWelcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 28, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Mainstay Medical has raised $125 million for its neurostimulation technology. Fast Five hosts Danielle Kirsh and Sean Whooley talk about the company's plans for the funds and what the implant does.
Philips has launched its new Azurion neuro biplane system for neurovascular interventions. Learn more about what Azurion does and how it he...2024-02-2811 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 50Deepthy Varghese, MSN, ACNP, FNP, of Northside Hospital, is joined by guests Sandeep K. Goyal, MD, FHRS, Piedmont Heart Institute, and Andrea M. Russo, MD, FHRS, Cooper University Hospital. to discuss the article explores that development and validation of the HARMS2-AF score, a novel lifestyle risk assessment tool for identifying atrial fibrillation (AF) risk in the general population. Using data from the UK Biobank and Framingham Heart Study, the score, derived through Cox proportional hazards regression, includes variables like hypertension, age, body mass index, sex, sleep apnea, smoking, and alcohol. Physical inactivity and diabetes were not significant predictors...2024-02-2217 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 49William H. Sauer, MD, FHRS, CCDS of Brigham and Women's Hospital, is joined by Uyanga Batnyam, MD of the University of Washington and Usha B. Tedrow, MD, MS, FHRS of Brigham and Women`s Hospital to discuss the risks of radiofrequency catheter ablation for ventricular arrhythmias include emboli and bleeding complications but data on antithrombotic regimens are limited and guidelines do not specify a systematic approach. This study sought to assess embolic and bleeding complications in relation to pre- and postperiprocedure antithrombotic regimens. Stroke is a rare complication of radiofrequency catheter ablation for ventricular arrhythmia using ASA 325 mg/d...2024-02-1517 min
Trending HealthMedTech Market MovesOver the last few years, the MedTech market has been navigating an unpredictable environment due to macro-economic factors and pandemic-driven activity. As we start off 2024, there’s a prevailing feeling that this market is finally starting to stabilize. In this episode, Jen is joined by Vynamic’s Anila Patel and Head of Health Technology Sector, Mary Virzi, to chat about what MedTech moves we’ve seen so far and what we can expect as 2024 kicks into gear. Podcast Tags: healthcare, medtech, product launch, medical device, health tech, healthcare technology Source Links: 2024-02-1514 minFast Five Medtech News PodcastJ&J's Cerenovus launches next-gen stroke revascularization catheterWelcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 9, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Baxter beat The Street in its fourth-quarter results as its kidney care spinoff progresses. Fast Five hosts Sean Whooley and Danielle Kirsh talk about the company's financial performance and how the spinoff is going.
The FDA has cleared Fresenius Medical Care's 5008X hemodialysis system. Hear more about the hemodialysis system and wh...2024-02-0908 minFast Five Medtech News PodcastLivaNova picks longtime J&J exec as CEO; 3M could reportedly raise up to $12B from spinoffWelcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 6, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Procyrion raised $57.7 million in a Series E funding round for its circulatory support device. Fast Five hosts Danielle Kirsh and Sean Whooley talk about what the funding will support, what its Aortix device is and what executives have to say about the funding raise.
Biosense Webster released positive Varipulse pulsed field ab...2024-02-0610 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 44William H. Sauer, MD, FHRS, CCDS, of Brigham and Women's Hospital, David Chang, MD, of Brigham and Women's Hospital, Sunil Kapur, MD, of Brigham and Women's Hospital to discuss why Intraprocedural imaging is critical for device delivery in transcatheter left atrial appendage occlusion (LAAO). Although pivotal trials of LAAO devices were conducted using transesophageal echocardiography (TEE), intracardiac echocardiography (ICE) is an emerging imaging modality. This study compared outcomes after ICE- and TEE-guided Watchman FLX implantation in the SURPASS (SURveillance Post Approval AnalySiS Plan) nationwide LAAO registry. https://www.hrsonline.org/education/TheLead https://www.jacc.org...2024-01-1117 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 42William H. Sauer, MD, FHRS, CCDS, of Brigham and Women's Hospital, is joined by guests Michael G. Katz, MD, FHRS, of Morristown Medical Center and Victor Nauffal, MD, of Brigham and Women`s Hospital, to discuss the treatment options for high-risk Brugada syndrome (BrS) with recurrent ventricular fibrillation (VF) and how it is limited. Catheter ablation is increasingly performed, but a large study with long-term outcome data is lacking. We report the results of the multicenter, international BRAVO (Brugada Ablation of VF Substrate Ongoing Registry) for treatment of high-risk symptomatic BrS. Ablation treatment is safe and highly effective in...2023-12-2115 minFast Five Medtech News PodcastMedtronic's pulsed-field ablation wins FDA approvalWelcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, December 15, 2023.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
HeartBeam this week unveiled an artificial intelligence program for cardiac insights. Fast Five hosts Sean Whooley and Danielle Kirsh discuss the goal of the AI program and HeartBeam's technology that will be used in the program.
Microbot Medical and Corewell are collaborating on telerobotics for endovascular surgical robotics. Hear what the go...2023-12-1509 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 40William H. Sauer, MD, FHRS, CCDS, of Brigham and Women's Hospital is joined by guests Michael A. Rosenberg, MD, FHRS, of University of Colorado Anschutz, and Jagmeet P. Singh, MD, PhD, FHRS, of Massachusetts General Hospital to discuss early detection of atrial fibrillation (AF) may help prevent adverse cardiovascular events such as stroke. Deep learning applied to electrocardiograms (ECGs) has been successfully used for early identification of several cardiovascular diseases. Deep learning of outpatient sinus rhythm ECGs predicted AF within 31 days in populations with diverse demographics and comorbidities. Similar models could be used in future AF screening efforts to...2023-12-0717 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 39Jason T. Jacobson, MD, FHRS, of Westchester Med Center-New York Med College, discusses the CAST trial with David J. Callans, MD, FHRS, CCDS of Hospital of the University of Pennsylvania, and Gerald V Naccarelli, MD, FHRS of Pennsylvania State University Milton S. Hershey Medical Center. Class IC antiarrhythmic drugs have been generally avoided in patients with any degree of coronary disease and any type of cardiomyopathy, whether or not they fit the inclusion criteria of the trial. For the past 3+ decades, the CAST trial results have been extrapolated to a broader population despite a lack of evidence. In this...2023-11-3020 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 36 William H. Sauer, MD, FHRS, CCDS, of Brigham and Women's Hospital is joined by guests Esseim Sharma, MD, of University Hospitals Cleveland, and Paul C Zei, MD, PhD, FHRS, of Brigham and Women's Hospital to discuss One-Year Outcomes Following Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia. Cardiac stereotactic body radiotherapy (SBRT) has emerged as a promising noninvasive treatment for refractory ventricular tachycardia (VT). The objective is to describe the safety and effectiveness of SBRT for VT in refractory to extensive ablation. For a select group of high-risk patients with VT refractory to standard therapy, SBRT is associated with a...2023-11-0919 minFast Five Medtech News PodcastAvail Medsystems abruptly shuts down; Cooper Cos. buys some of Cook Medical's product linesWelcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, November 3, 2023.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Biosense Webster this week posted positive data for its QDOT Micro ablation catheter. Fast Five hosts Sean Whooley and Danielle Kirsh go over some of the key data points that stuck out from the study and the optimism that executives have with this news.
Silk Road Medical named its new CEO af...2023-11-0309 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 35Jason T. Jacobson, MD, FHRS, of Westchester Med Center-New York Med College discusses A Novel ECG-Based Deep Learning Algorithm to Predict Cardiomyopathy in Patients With Premature Ventricular Complexes with Daniel Frenkel, MD, FHRS, of Westchester Medical Center, and Jagmeet P. Singh, MD, PhD, FHRS, of Massachusetts General Hospital. This study utilized a machine learning algoritihm to predict the devlopment of cardiomyopathy in patients with PVCs based on the baseline ECG. https://www.hrsonline.org/education/TheLead https://www.jacc.org/doi/10.1016/j.jacep.2023.05.025 Host Disclosure(s): J. Ja...2023-11-0220 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 34William H. Sauer, MD, FHRS, CCDS, of Brigham and Women's Hospital is joined by guests Sunil Kapur, MD, of Brigham and Women's Hospital, and Joshua M. Cooper, MD, FHRS, of Temple University Health System to discuss Intra-Pocket Ultrasound-Guided Axillary Vein Puncture vs. Cephalic Vein Cutdown for Cardiac Electronic Device Implantation: The ACCESS Trial. Intra-pocket ultrasound-guided axillary vein puncture (IPUS-AVP) for venous access in implantation of transvenous cardiac implantable electronic devices (CIED) is uncommon due to the lack of clinical evidence supporting this technique. This study investigated the efficacy and early complications of IPUS-AVP compared to the standard method using...2023-10-3117 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 33Michael S. Lloyd, MD, FHRS, of Emory University is joined by guests T. Jared Bunch, MD, FHRS, of University of Utah School of Medicine, and Amit Shah MD, MSCR, of Emory University to discuss Atrial Fibrillation Catheter Ablation vs Medical Therapy and Psychological Distress - A Randomized Clinical Trial. https://www.hrsonline.org/education/TheLead https://jamanetwork.com/journals/jama/article-abstract/2809419 Host Disclosure(s): M. Lloyd: Honoraria/Speaking/Consulting Fee: Medtronic, Baylis Medical Company, Boston Scientific Contributor Disclosure(s): T. Bunch: Honoraria/Speaking/Co...2023-10-2619 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 31William H. Sauer, MD, FHRS, CCDS, of Brigham and Women's Hospital is joined by guests Thomas Tadros, MD, and Ashraf Sabe, MD, of Brigham and Women's Hospital, to discuss efficacy and safety of hybrid epicardial and endocardial ablation versus endocardial ablation in patients with persistent and longstanding persistent atrial fibrillation. In this randomized trial, hybrid surgical and catheter ablation was more effective than catheter ablation alone in persistent atrial fibrillation without significant procedural risk increase. https://www.hrsonline.org/education/TheLead https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00229-8/fulltext 2023-10-1914 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 29Christopher C. Cheung, MD, MPH, of Sunnybrook Health Sciences Centre, University of Toronto, is joined by guests Edward P. Gerstenfeld, MD, FHRS, of University of California, San Francisco, and Paul C. Zei, MD, PhD, FHRS, of Brigham and Women's Hospital to discuss the benefits and risks associated with pulsed field ablation and conventional thermal ablation in the content of paroxysmal atrial fibrillation. https://www.hrsonline.org/education/TheLead https://www.nejm.org/doi/full/10.1056/NEJMoa2307291 Host Disclosure(s): C. Cheung: No relevant financial relationships with ineligible companies to dis...2023-10-1221 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 28William H. Sauer, MD, FHRS, CCDS, of Brigham and Women's Hospital is joined by guests Erik Andrews, MD, MPH, and Christian Thomas Ruff, MD, MPH, of Brigham and Women's Hospital to discuss Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial. In the FRAIL-AF clinical trial, there were more bleeding events when elderly patients were switched from warfarin to rivaroxaban, apixaban, edoxaban, or dabigatran. https://www.hrsonline.org/education/TheLead https://www.ahajournals.or...2023-10-1018 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 27Joshua D. Moss, MD, FHRS, of University of California, San Francisco is joined by guests Thomas A Dewland, MD, FHRS, of University of California, San Francisco, and Nathaniel Steiger, MD, of Brigham and Women's Hospital to discuss Utility and Limitations of Ablation Index for Guiding Therapy in Ventricular Myocardium. The Ablation Index (AI) has limited value for guiding ablation in ventricular myocardium, particularly scar. This may be related to small proportional significance of application duration and complex tissue architecture. https://www.hrsonline.org/education/TheLead https://www.jacc.org/doi/10.1016/j.jacep.2023.03.020 2023-10-0519 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 25Deepthy Varghese, MSN, ACNP, FNP, of Northside Hospital is joined by Alok Gambhir, MD, DPhil, FHRS, of Northside Hospital, and Megan LaBreck, PharmD, BCPD, CACP, of Riverside Methodist Hospital to discuss Feasibility and Safety of Intravenous Sotalol Loading in Adult Patients With Atrial Fibrillation (DASH-AF). https://www.hrsonline.org/education/TheLead https://www.jacc.org/doi/10.1016/j.jacep.2022.11.026 Host Disclosure(s): D. Varghese: No relevant financial relationships with ineligible companies to disclose. Contributor Disclosure(s): A. Gambhir: Honoraria/Speaking/Consulting Fee: Boston Sc...2023-09-2819 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 24William H. Sauer, MD, FHRS, CCDS, of Brigham and Women's Hospital is joined by Kolade Muchaili Agboola, MD, and Akshay Suvas Desai, MD, MPH, of Brigham and Women's Hospital to discuss the results and implications of the CASTLE-HTx trial. https://www.hrsonline.org/education/TheLead Host Disclosure(s): W. Sauer: Honoraria/Speaking/Consulting Fee: Biotronik, Biosense Webster, Inc., Abbott, Boston Scientific; Research (Contracted Grants for PIs Named Investigators Only): Medtronic Contributor Disclosure(s): K. Agboola: No relevant financial relationships with ineligible companies to disc...2023-09-2617 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 22Michael S. Lloyd, MD, FHRS of Emory University discusses Catheter Ablation of Atrial Fibrillation in Adult Congenital Heart Disease: Procedural Characteristics and Outcomes with Natasja M. S. De Groot, MD, PhD, of Erasmus University Medical Center, and Jeremy P. Moore, MD, MS, FHRS, CCDS, CEPS-P, of UCLA Medical Center. https://www.hrsonline.org/education/TheLead Host Disclosure(s): M. Lloyd: Honoraria/Speaking/Consulting Fee: Medtronic, Baylis Medical Company, Boston Scientific Contributor Disclosure(s): N. De Groot: Honoraria/Speaking/Consulting Fee: Biosense Webster J...2023-09-2116 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 20William H. Sauer, MD, FHRS, CCDS, of Brigham and Women's Hospital is joined by guests David Chiang, MD, PhD, and Sunil Kapur MD, of Brigham and Women's Hospital to discuss (RAPID): A Multicentre, Randomised Trial. Etripamil is a fast-acting, intranasally administered calcium-channel blocker in development for ondemand therapy outside a health-care setting for paroxysmal supraventricular tachycardia. The authors of this randomized trial evaluated the efficacy and safety of etripamil 70 mg nasal spray using a symptom-prompted, repeat-dose regimen for acute conversion of atrioventricular-nodal-dependent paroxysmal supraventricular tachycardia to sinus rhythm within 30 min. https://www.hrsonline.org/education/T...2023-09-1416 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 18Jason T. Jacobson, MD, FHRS, of Westchester Med Center-New York Med College is joined by guests, David S. Frankel, MD, FHRS, of the Hospital of the University of Pennsylvania, and Usha B. Tedrow, MD, MS, FHRS, of Brigham and Women's Hospital, to discuss substrate mapping altering ventricular tachycardia inducibility. The authors performed a retrospective analysis of the reproducibility of programmed stimulation for the first induction of ventricular tachycardia in those with and without intervening voltage mapping. This was study was not randomized. All subjects had 2 rounds of programmed stimulation separated in time. One group underwent intracardiac echocardiographic mapping in b...2023-09-0720 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 17William H. Sauer, MD, FHRS, CCDS, of Brigham and Women's Hospital is joined by guests Bruce A. Koplan, MD, MPH, FHRS, and Victor Nauffal, MD, of Brigham and Women's Hospital, to discuss Procedure-Related Complications of Catheter Ablation for Atrial Fibrillation. In this study, online publication databases were searched for randomized trials that included patients undergoing a first ablation procedure of atrial fibrillation using either radiofrequency or cryoballoon. A total of 1,468 references were retrieved, of which 89 studies met the inclusion criteria, yielding a total of 15,701 patients included in the analysis. The reported overall and severe procedure-related complication rates were 4.51% and 2.44...2023-08-3114 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 16Prashanthan Sanders, MBBS, PhD, FHRS, of University of Adelaide is joined by guests Dhiraj Gupta, MBBS, MD, of Liverpool Heart and Chest Hospital, and Tina Baykaner, MD, MPH, of Stanford University, to discuss same-day discharge (SDD) after catheter ablation of atrial fibrillation (AF) has been widely adopted. Nevertheless, planned SDD has been performed by using subjective criteria rather than standardized protocols. The goal of this study was to determine the efficacy and safety of the previously described SDD protocol in a prospective multicenter study. In this large, multicenter prospective registry, the use of a standardized protocol showed the safety of...2023-08-3114 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 12 William H. Sauer, MD, FHRS, CCDS, is joined by guests Jorge Romero, Jr., MD, FHRS, and Esseim Sharma, MD, for a discussion of the comparison of left bundle-branch area pacing to biventricular pacing in candidates for resynchronization therapy. This observational study included patients with LVEF≤35% who underwent biventricular or left bundle area pacing for the first time for Class I or II indications at 15 international centers. The primary outcome was the composite endpoint of time to death or heart failure hospitalization. Secondary outcomes included endpoints of death, HFH, and echocardiographic changes. Following implantation, LVEF improved from 27 to 41% with left bu...2023-08-1714 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 11 Jason T. Jacobson, MD, FHRS, is joined by guests Laurent Macle, MD, FHRS, and Peter M. Kistler, MBBS, PhD, FHRS, for a discussion of the Improved PAF Trial. Prior studies have demonstrated clinical benefits associated with cryoballoon pulmonary vein isolation (PVI) and concomitant posterior wall isolation (PWI) in patients with persistent atrial fibrillation (AF). However, the role for this approach in patients with paroxysmal atrial fibrillation (PAF) remains unclear. Compared with cryoballoon PVI, cryoballoon PVI+PWI appears to be associated with greater freedom from recurrent atrial arrhythmias and AF in patients with PAF during long-term follow-up >3 years. ...2023-08-1018 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 10 William H. Sauer, MD, FHRS, CCDS, is joined by guests Nathaniel Steiger, MD, and Paul C. Zei, MD, PhD, FHRS, for a discussion on the PULSED AF Pivotal Trial. This was a prospective, global, multicenter, nonrandomized, paired single-arm study in which patients with paroxysmal (n=150) or persistent (n=150) symptomatic atrial fibrillation (AF) refractory to class I or III antiarrhythmic drugs were treated with pulsed field ablation. The results demonstrate similar efficacy compared with clinical studies evaluating radiofrequency ablation and cryothermal ablation. Safety with the new form of ablation technology appeared to be promising with no evidence of esophageal injury...2023-08-1013 minFast Five Medtech News PodcastStryker launches Mako direct-to-patient marketing campaign, Tivic Health's $1.4M offeringTivic Health this week announced that it priced a public offering of common stock. The company plans to use the net proceeds for working capital and general corporate purposes. Fast Five hosts Sean Whooley and Danielle Kirsh explain what the offering includes and give details on the upcoming special stockholder meeting.
Masimo's SedLine brain function monitoring could improve brain monitoring during endoscopy, according to a new study. Find out the key details of the study and how it assesses sedation levels during procedures.
The FDA clearance of Abbott's Alinity h-series hematology system represents a significant milestone for the company, as i...2023-08-0809 minFast Five Medtech News PodcastJ&J looks to split-off a business unit, Inspire Medical appoints former Medtronic execPhilips recently announced Q2 results and an update on the ongoing DOJ talks and layoffs. Industry analysts may discuss Philips' forward-looking plans to mitigate order intake volatility and maintain a competitive edge in the medical device market. Fast Five hosts Sean Whooley and Danielle Kirsh discuss the quarterly results and what the current status of the ongoing consent decree.
The launch of Biosense Webster's AFib mapping catheter signifies J&J's commitment to advancing cardiac ablation technologies for atrial fibrillation patients. Hear how the technology works, how it could benefit clinicians and what doctors and executives think about it.
This week...2023-07-2510 minThe Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 4 Michael S. Lloyd, MD, FHRS of Emory University discusses the Impact of Early Versus Delayed Atrial Fibrillation Catheter Ablation on Atrial Arrhythmia Recurrences. He is joined by guests Jason G. Andrade, MD, FHRS of Vancouver General Hospital and Stefan H. Hohnloser, MD, FHRS of J. W. Goethe University. https://www.hrsonline.org/education/TheLead Host Disclosure(s): M. Lloyd: Honraria/Speaking/Consulting Fee: Medtronic, Baylis Medical Company, Boston Scientific Contributor Disclosure(s): J. Andrade: Honoraria/Speaking/Consulting Fee: Medtronic, Bayer Healthcare Pharmaceuticals, Bristol-Myers Squibb, Servier, Baylis Medical Company, Bios...2023-07-1315 min
The Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 3 A Discussion of Magnetic Resonance Imaging Based Dual Lead Cardiac Resynchronization Therapy. Prashanthan Sanders, MBBS, PhD, FHRS of the University of Adelaide as he discusses Magnetic resonance imaging based Dual lead cardiac Resynchronization therapy: A prospective Left Bundle Branch Pacing Study (MADURAI LBBP study) by Heart Rhythm 2023 Late-Breaking Abstract Author Shunmuga Sundaram Ponnusamy. He is joined by guests Rakesh Gopinathannair, MA, MD, FHRS of the Kansas City Heart Rhythm Institute and Martin K. Stiles, MBChB, PhD, FHRS of Waikato Hospital, Cardiology. This episode of The Lead was recorded in front of live audience at Heart Rhythm 2023 in New Orleans, Lousiana. 2023-07-1013 min
The Lead Podcast presented by Heart Rhythm SocietyThe Lead Podcast - Episode 2A Discussion of Epicardial Roof-Dependent Macro-Reentrant Tachycardia. Jason T. Jacobson, MD, FHRS of Westchester Medical Center – New York Medical College and co-host Danesh Kella, MBBS, FHRS of the Mayo Clinic Jacksonville as they discuss the article Epicardial Roof-Dependent Macro-Reentrant Tachycardia After Ablation of Atrial Fibrillation: Prevalence, Electrophysiological Characteristics, and Ablation Strategy. They are joined by guests Pierre Jais, MD of the Université of Bordeaux, CHU Bordeaux, IHU LIRYC and Apoor Patel, MD of Houston Methodist Hospital. This episode was recorded in front of a live audience at Heart Rhythm 2023 in New Orleans, Lousiana. https://www.hrsonline.org/edu...2023-07-1022 minFast Five Medtech News PodcastJ&J's Biosense Webster names new president, Paradromics raises $33M for BCI techIn a significant development, the FDA has cleared Abbott's insertable cardiac monitor, marking an important advancement in cardiac care. This device offers healthcare professionals a valuable tool for long-term monitoring of patients' heart rhythms, enabling early detection and timely intervention. Fast Five hosts Sean Whooley and Danielle Kirsh detail what the device does and how optimistic executives at the company are.
Paradromics has raised $33 million in funding. This substantial investment reflects the growing interest and potential of brain-computer interfaces in revolutionizing how we interact with technology and understand the human brain. Whooley and Kirsh discuss how the technology works and...2023-05-1910 minFast Five Medtech News PodcastMedtronic, J&J reportedly eye an acquisition, Onward implants first movement-restoring leadOn today's episode, Fast Five Hosts Danielle Kirsh and Sean Whooley discuss new data from Biosense Webster's radiofrequency ablation system. The study results suggest better treatment of atrial fibrillation using the company's QDOT catheter. This breakthrough technology offers promising results for patients suffering from this common heart rhythm disorder, providing new possibilities for more effective treatment options.
BrainsWay has launched a study program aimed at evaluating the effectiveness of its deep transcranial magnetic stimulation (dTMS) technology. The technology is used to treat several neurological and psychiatric conditions, including depression, obsessive-compulsive disorder, and smoking cessation. Whooley gives an inside look at...2023-05-1611 min
MedChatManagement of Atrial Fibrillation in Primary CareManagement of Atrial Fibrillation in Primary Care Evaluation and Credit: https://www.surveymonkey.com/r/MedChat52 Target Audience This activity is targeted toward primary care and geriatric healthcare providers and advanced providers. Statement of Need A common chronic condition seen in the primary care setting is atrial fibrillation. The management of this disease can be complicated with many facets. Providers should be aware of the risk factors of untreated a-fib; as well as how to recognize, screen and manage the condition. Additionally, providers should incorporate the latest screening and treatment options for optimal care of their patients, minimizing their risks of complication...2023-05-1128 min
Awakened NationShould We Be Afraid of AI?, with Science Fiction author Robert RivenbarkShould we be afraid of Artificial Intelligence AI? Science Fiction author Robert Rivenbark posed that exact same question when he wrote The Cloud. A combination of The Peripheral, Johnny Mnemonic and Blade Runner, The Cloud answers a simple question: if AI and Virtual Reality VR were combined...what kind of world would we be living in? And more sinister, what if those in power controlled this artificial world, programming it to keep the peasant class dumbed down, ignorant and domesticated? Robert Rivenbark sits down to have a fascinating discussion on the link between his work...2023-05-0351 min
DeviceTalks Podcast NetworkShifamed Start-Up Tioga Cardiovascular looking to redefine mitral and tricuspid valve replacementIn this podcast episode, Co-Hosts Tom Salemi and Chris Newmarker review how the medtech industry is handing the current shrinking job market. They’ll review this week’s Newmarker’s Newsmakers which includes Medtronic, Biosense Webster, Johnson & Johnson and high profile clinical meetings. Tom then interviews Mike Dineen, CEO of Tioga Cardiovascular, which is pushing the limits for heart valves. Tioga emerged from the prolific Shifamed incubator. Dineen gives history on both Shifamed and Tioga.
To learn more about the FTC’s review of non-competes go here. https://www.ftc.gov/news-events/news/press-releases/2023/03/ftc-extends-public-comment-period-its-proposed-rule-ban-noncompete-clauses-until-april-19
Thanks for listening to the DeviceTa...2023-03-1151 minDeviceTalks Podcast NetworkShifamed Start-Up Tioga Cardiovascular looking to redefine mitral and tricuspid valve replacementIn this podcast episode, Co-Hosts Tom Salemi and Chris Newmarker review how the medtech industry is handing the current shrinking job market. They’ll review this week’s Newmarker’s Newsmakers which includes Medtronic, Biosense Webster, Johnson & Johnson and high profile clinical meetings. Tom then interviews Mike Dineen, CEO of Tioga Cardiovascular, which is pushing the limits for heart valves. Tioga emerged from the prolific Shifamed incubator. Dineen gives history on both Shifamed and Tioga.
To learn more about the FTC’s review of non-competes go here. https://www.ftc.gov/news-events/news/press-releases/2023/03/ftc-extends-public-comment-period-its-proposed-rule-ban-noncompete-clauses-until-april-19
Thanks for listening to the DeviceTa...2023-03-1151 min
Cameron-BrooksEpisode 158 – 5 Steps to JMO Business Career SuccessWelcome back to another episode of the Cameron-Brooks Podcast. Do you want to make a successful transition from military to business? Do you want to be in a top leadership role of a leading company? If you do, you don’t need to reinvent the wheel to help you get there. You can follow former military officers who have become key business leaders’ steps for career success.
One such former military officer I recommend following is Ben Berkowick. I first met Ben in Pensacola, FL in December of 2008. At that time, Ben was a Navy Naval Flight Officer...2022-10-0440 min
Denise Griffitts - Your Partner In Success™ Radio!Robert Rivenbark - Interview With Author of The CloudThe act of writing is an act of communication. When we write, we are creating something that did not exist before.
Robert Rivenbark earned a master’s degree in Creative Writing from Antioch University after winning a full academic scholarship to study for two years in Oxford and London, England, based on his winning short story collection. His experience there gave him global perspective as a storyteller. He returned to the U.S. for a career in journalism and advertising and worked as a senior copywriter and video producer for some of America’s most prestigious advertising agenc...2022-09-301h 01
Atrial Fibrillation Archives - Cardionerds208. Atrial Fibrillation: Epidemiology, Health Equity, & The Double Paradox with Dr. Larry Jackson
Atrial fibrillation may reach pandemic proportions in the next 2-3 decades. Factors that drive this phenomenon have been studied in predominantly White populations, leading to a significant underrepresentation of certain racial/ethnic groups in atrial fibrillation epidemiological studies. Most atrial fibrillation epidemiology studies suggest that the non-Hispanic Black population has a lower incidence/prevalence of atrial fibrillation, despite a higher risk factor burden (“Afib paradox”). At the same time, non-Hispanic Blacks have worse outcomes compared to the White population and underrepresented populations and women are less likely than White men to receive optimal guideline-based therapies for atrial fibrillation.
In...2022-05-2038 minEpisodes Archives - Cardionerds208. Atrial Fibrillation: Epidemiology, Health Equity, & The Double Paradox with Dr. Larry Jackson
Atrial fibrillation may reach pandemic proportions in the next 2-3 decades. Factors that drive this phenomenon have been studied in predominantly White populations, leading to a significant underrepresentation of certain racial/ethnic groups in atrial fibrillation epidemiological studies. Most atrial fibrillation epidemiology studies suggest that the non-Hispanic Black population has a lower incidence/prevalence of atrial fibrillation, despite a higher risk factor burden (“Afib paradox”). At the same time, non-Hispanic Blacks have worse outcomes compared to the White population and underrepresented populations and women are less likely than White men to receive optimal guideline-based therapies for atrial fibrillation.
In...2022-05-2038 minCardionerds: A Cardiology Podcast208. Atrial Fibrillation: Epidemiology, Health Equity, & The Double Paradox with Dr. Larry JacksonAtrial fibrillation may reach pandemic proportions in the next 2-3 decades. Factors that drive this phenomenon have been studied in predominantly White populations, leading to a significant underrepresentation of certain racial/ethnic groups in atrial fibrillation epidemiological studies. Most atrial fibrillation epidemiology studies suggest that the non-Hispanic Black population has a lower incidence/prevalence of atrial fibrillation, despite a higher risk factor burden (“Afib paradox”). At the same time, non-Hispanic Blacks have worse outcomes compared to the White population and underrepresented populations and women are less likely than White men to receive optimal guideline-based therapies for atrial fibrillation.
In this epis...2022-05-2038 min
Med Device CareersEpisode 002: Becoming a Subject Matter Expert with Uri Yaron, Worldwide President of Biosense WebsterIn this episode we speak with Uri Yaron, Worldwide President of Biosense Webster. In our conversation, we discuss Uri’s entry point into the medical device space, why Israel is a hub for medtech, the culture of innovation at Biosense Webster within the greater Johnson & Johnson ecosystem, and becoming a subject matter expert early in one’s career.
Uri began his career at Biosense Webster in 1997, where he has held a number of positions of increasing responsibility in R&D, Business Development, and currently as Worldwide President. Uri is known as a strategic leader who has established outst...2021-08-2721 min
The BME Grad Podcast10- Clinical Account Specialist at Biosense Webster w/ Brooke GurnariBrooke Gurnari is a 2019 grad of the Joint Program of BME at UNC and NC state. Brooke joins Allie and Grace to talk about her role at Biosense Webster and her exciting day-to-day schedule, interacting with doctors, nurses, and patients.
For more information on The BME Grad Podcast, visit the Joint Department of BME at UNC and NC State's website: bme.unc.edu/home/news-events/the-bme-grad-podcast/
Connect with or reach out to Host, Allie Mitzak, on LinkedIn: www.linkedin.com/in/allie-mitzak
---
Support this p...2021-03-2525 min
Keck Graduate Institute: Insights and innovations in Healthcare, Biotech, and Life Sciences Research#124 - Neelu GibsonAs part of KGI's Industry Talk Series, our most recent guest was Neelu Gibson. Gibson serves as the Worldwide Vice President, Regulatory Affairs, Medication Management Solutions (MMS), at BD Medical. She is proud to lead a dynamic team of global professionals in creating and executing regulatory strategies and submissions facilitating the availability of the MMS portfolio of products to healthcare professionals and patients worldwide. Prior to joining BD in February 2020, Neelu spent 20+ years with the Johnson & Johnson Family of Companies (J&J), where she held positions of increasing responsibility in Regulatory Affairs at Advanced Sterilization Products, Biosense...2020-10-0847 minCameron-BrooksCameron-Brooks Podcast Episode 5: Building Your Network and Personal Brand and Working HardRoss Nussbaum is a former USMC Infantry Officer who transitioned through Cameron-Brooks in 2013 and, today, is a Territory Manager at Biosense Webster, Inc., part of the Johnson & Johnson family of companies. Essentially, Ross manages a geographic territory while advising physicians in surgery on the proper use and application of products associated with the treatment of Atrial Fibrillation (AFib). Ross has been incredibly successful and has been promoted multiple times in his 3+ years with Biosense Webster, Inc. In this episode, Ross shares insights on:
Surrounding himself with high-performing co-workers and building a professional network
Building his personal brand
Taking owner...2016-07-2635 min